These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 24034848)

  • 41. Notch1 downregulation combined with interleukin-24 inhibits invasion and migration of hepatocellular carcinoma cells.
    Han B; Liu SH; Guo WD; Zhang B; Wang JP; Cao YK; Liu J
    World J Gastroenterol; 2015 Sep; 21(33):9727-35. PubMed ID: 26361419
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ShRNA-targeted COMMD7 suppresses hepatocellular carcinoma growth.
    Zheng L; Liang P; Li J; Huang XB; Liu SC; Zhao HZ; Han KQ; Wang Z
    PLoS One; 2012; 7(9):e45412. PubMed ID: 23049798
    [TBL] [Abstract][Full Text] [Related]  

  • 43. shRNA-mediated silencing of Gli2 gene inhibits proliferation and sensitizes human hepatocellular carcinoma cells towards TRAIL-induced apoptosis.
    Zhang D; Liu J; Wang Y; Chen J; Chen T
    J Cell Biochem; 2011 Nov; 112(11):3140-50. PubMed ID: 21695716
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neuregulin/erythroblastic leukemia viral oncogene homolog 3 autocrine loop contributes to invasion and early recurrence of human hepatoma.
    Hsieh SY; He JR; Hsu CY; Chen WJ; Bera R; Lin KY; Shih TC; Yu MC; Lin YJ; Chang CJ; Weng WH; Huang SF
    Hepatology; 2011 Feb; 53(2):504-16. PubMed ID: 21246584
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of livin in gastric cancer and induction of apoptosis in SGC-7901 cells by shRNA-mediated silencing of livin gene.
    Wang TS; Ding QQ; Guo RH; Shen H; Sun J; Lu KH; You SH; Ge HM; Shu YQ; Liu P
    Biomed Pharmacother; 2010 May; 64(5):333-8. PubMed ID: 19914791
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Down-regulating glypican-3 expression: molecular-targeted therapy for hepatocellular carcinoma.
    Dong Z; Yao M; Wang L; Yang J; Yao D
    Mini Rev Med Chem; 2014; 14(14):1183-93. PubMed ID: 25553423
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Simultaneous silencing of β-catenin and signal transducer and activator of transcription 3 synergistically induces apoptosis and inhibits cell proliferation in HepG2 liver cancer cells.
    Wang XH; Liu MN; Huang P; Xu J; Liu AY; Chen J; Lv CQ; Xu RL
    Mol Med Rep; 2015 Aug; 12(2):2263-8. PubMed ID: 25845340
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effect of silencing HIF-1alpha by RNA interference on expression of vascular endothelial growth factor in osteosarcoma cell line SaOS-2 under hypoxia].
    Wu Q; Yang SH; Wang RY; Ye SN; Xia T; Ma DZ
    Ai Zheng; 2005 May; 24(5):531-5. PubMed ID: 15890092
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.
    Frau M; Ladu S; Calvisi DF; Simile MM; Bonelli P; Daino L; Tomasi ML; Seddaiu MA; Feo F; Pascale RM
    J Hepatol; 2011 Jul; 55(1):111-9. PubMed ID: 21419759
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of periostin gene expression via RNA interference suppressed the proliferation, apoptosis and invasion in U2OS cells.
    Liu C; Huang SJ; Qin ZL
    Chin Med J (Engl); 2010 Dec; 123(24):3677-83. PubMed ID: 22166650
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [ShRNA-mediated gene silencing of beta-catenin inhibits growth of human colon cancer cell Colo205 in vitro].
    Huang WS; Peng H; Tan M; Ma JP; Wang JP; Lan P
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 May; 12(3):301-5. PubMed ID: 19434544
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Down-regulation of c-Met expression inhibits human HCC cells growth and invasion by RNA interference.
    Xie B; Xing R; Chen P; Gou Y; Li S; Xiao J; Dong J
    J Surg Res; 2010 Aug; 162(2):231-8. PubMed ID: 19765730
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma.
    Kim KW; Bae SK; Lee OH; Bae MH; Lee MJ; Park BC
    Cancer Res; 1998 Jan; 58(2):348-51. PubMed ID: 9443416
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver.
    Gray MJ; Van Buren G; Dallas NA; Xia L; Wang X; Yang AD; Somcio RJ; Lin YG; Lim S; Fan F; Mangala LS; Arumugam T; Logsdon CD; Lopez-Berestein G; Sood AK; Ellis LM
    J Natl Cancer Inst; 2008 Jan; 100(2):109-20. PubMed ID: 18182619
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A new membrane re-anchored protein originating from GPC3 against hepatoma cells HepG2.
    Yang D; Yang J; Lu F; Li C; Yang J; Liang J
    Mol Med Rep; 2011; 4(6):1067-73. PubMed ID: 21904776
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Effects of small interfering RNA specific to stably transfected HMGA1 gene on biological characters of ovarian carcinoma cells].
    Liu YL; Zheng JH
    Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):51-5. PubMed ID: 20367927
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ShRNA-mediated gene silencing of beta-catenin inhibits growth of human colon cancer cells.
    Huang WS; Wang JP; Wang T; Fang JY; Lan P; Ma JP
    World J Gastroenterol; 2007 Dec; 13(48):6581-7. PubMed ID: 18161931
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of silencing PARG in human colon carcinoma LoVo cells on the ability of HUVEC migration and proliferation.
    Pan J; Fauzee NJ; Wang YL; Sheng YT; Tang Y; Wang JQ; Wu WQ; Yan JX; Xu J
    Cancer Gene Ther; 2012 Oct; 19(10):715-22. PubMed ID: 22918473
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Overexpression and role of the ATPase and putative DNA helicase RuvB-like 2 in human hepatocellular carcinoma.
    Rousseau B; Ménard L; Haurie V; Taras D; Blanc JF; Moreau-Gaudry F; Metzler P; Hugues M; Boyault S; Lemière S; Canron X; Costet P; Cole M; Balabaud C; Bioulac-Sage P; Zucman-Rossi J; Rosenbaum J
    Hepatology; 2007 Oct; 46(4):1108-18. PubMed ID: 17657734
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Down-regulated clusterin expression enhances sensitivity of hepatoma cells to anti-cancer drugs].
    Zheng WJ; Sai WL; Yao M; Cai Y; Pan LH; Gu JJ; Wu W; Yao DF
    Zhonghua Gan Zang Bing Za Zhi; 2015 Nov; 23(11):844-8. PubMed ID: 26743245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.